Leap Therapeutics Inc [LPTX] stock is trading at $0.42, up 7.95%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LPTX shares have gain 5.85% over the last week, with a monthly amount glided 37.04%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Leap Therapeutics Inc [NASDAQ: LPTX] stock has seen the most recent analyst activity on January 29, 2025, when Robert W. Baird downgraded its rating to a Neutral and also revised its price target to $1.25 from $9. Previously, H.C. Wainwright downgraded its rating to Neutral on January 29, 2025. On June 28, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $8 on the stock. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $6 on October 04, 2021. Piper Sandler started tracking with a Overweight rating for this stock on June 29, 2020, and assigned it a price target of $6. In a note dated February 11, 2020, Robert W. Baird initiated an Outperform rating and provided a target price of $6 on this stock.
Leap Therapeutics Inc [LPTX] stock has fluctuated between $0.22 and $4.79 over the past year. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Leap Therapeutics Inc [NASDAQ: LPTX] shares were valued at $0.42 at the most recent close of the market. An investor can expect a potential return of 1209.52% based on the average LPTX price forecast.
Analyzing the LPTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.38, Equity is -1.37 and Total Capital is -2.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3887 points at the first support level, and at 0.3594 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4387, and for the 2nd resistance point, it is at 0.4594.
Ratios To Look Out For
For context, Leap Therapeutics Inc’s Current Ratio is 3.41. As well, the Quick Ratio is 3.41, while the Cash Ratio is 3.36.
